Page last updated: 2024-09-03

2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and calmidazolium

2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with calmidazolium in 1 studies

Compound Research Comparison

Studies
(2-aminobicyclo(2,2,1)heptane-2-carboxylic acid)
Trials
(2-aminobicyclo(2,2,1)heptane-2-carboxylic acid)
Recent Studies (post-2010)
(2-aminobicyclo(2,2,1)heptane-2-carboxylic acid)
Studies
(calmidazolium)
Trials
(calmidazolium)
Recent Studies (post-2010) (calmidazolium)
166034550039

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sampaio-Maia, B; Soares-Da-Silva, P1

Other Studies

1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and calmidazolium

ArticleYear
Inhibition of calcium-independent luminal uptake of L-dopa by calmodulin antagonists in immortalized rat capillary cerebral endothelial cells.
    Cell biology international, 2001, Volume: 25, Issue:3

    Topics: Amino Acids, Cyclic; Aminoisobutyric Acids; Animals; Biological Transport; Calcium Channels, L-Type; Calmodulin; Cell Line; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazoles; Inhibitory Concentration 50; Levodopa; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Signal Transduction; Sodium; Telencephalon; Time Factors; Trifluoperazine

2001